1Chung SS, Blackshear JL, Shen WK, et al. Epidemiology and natund history of atrial fibrillation clinical implications[ J]. J Am Coll Cardiol,2001,37 (2) :371-378.
3Brains P,Te Velthuis H,Yazdanbakhsh AP,et al. Activation of the corm plement system during and after cardiopulmonary bypass surgery:postsurgery activation involves C-reactive protein and is associated with postoperative anhythmia[ J]. Circulation,1997,9(10) :3 542-3 548.
4Chung MK,Martin DO,Sprecher D ,et al. C-reactive protein elevation in patients with atrial anhythmias:inflammatory mechanisms and persistence of atrial fibrillation[J]. Criculation,2001,104(24) :2 886 -2 891.
5Dernellis J,Panareton M. C-reactive protein and paroxysmal atrial fibrillation:evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation[J]. Acta Cardiol,2001,56(6) :375 -380.
6Aviles RJ, Martin DO, Apperaon Hansen C, et al. Inflammation as a risk factor for atrial fibrillation [ J ]. Circulation, 2003, 108 ( 24 ) : 3 006 -3 010.
10Ustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation [ J ]. Circulation, 1997, 96(4) :1 180 -1 184.
二级参考文献54
1Fromer M,Genton C,Schlaepfer J,et al.Is there an isolated arrhythmogenic right atrial myocarditis? Eur Heart J,1990,11:566-571.
2Frustaci A,Chimenti C,Bellocci F,et al.Histological substrate of atrial biopsies in patients with lone atrial fibrillation.Circulation,1997,96:1180-1184.
3Bruins P,te Velthuis H,Yazdanbakhsh AP,et al.Activation of the complement system during and after cardiopulmonary bypass surgery:postsurgery activation involves C-reactive protein and is associated vith postoperative arrhythmia.Circulation,1997,96:3542-3548.
4Chung MK,Martin DO,Sprecher D,et al.C-reactive protein elevation in patients with atrial arrhythmias:inflammatory mechanisms and persistence of atrial fibrillation.Circulation,2001,104:2886-2891.
5Aviles RJ,Martin DO,Apperson-Hansen C.Inflammation as a risk factor for atrial fibrillation.Circulation,2003,108:3006 -3010.
6Conway DS,Buggins P,Hughes E,et al.Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation.Am J Cardiol,2004,94:508-510.
7Watanabe E,Arakawa T,Uchiyama T,et al.High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.Int J Cardiol,2006,108:346-353.
8Roldan V,Marin F,Blann AD,et al.Interleukin-6,endothelial activation and thrombogenesis in chronic atrial fibrillation.Eur Heart J,2003,24:1373-1380.
9Gershov D,Kim S,Brot N,et al.C-reactive protein binds to apoptotic cells,protects the cells from assembly of the terminal complement components,and sustains an antiinflammatory innate immune response:implications for systemic autoimmunity.J Exp Med,2000,192:1353-1364.
10Kumagai K,Nakashima H,Saku K.The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model.Cardiovasc Res,2004,62:105-111.
1Wang TJ, Parise H, Levy D,et al. Obesity and the risk of new-onsetatrial fibrillation[J]. JAMA, 2004,292:2471-2477.
2Lin YK, Chen YJ, Chen SA, et al. Potential atrial arrhythmogenicity ofadipocytes: Implications for the genesis of atrial fibrillation [J]. Medi-cal Hypotheses, 2010,74:1026-1029.
3L6 pez-Jim6 nez F,Cort6 s-Bergoderi M, et al. Obesity and the HeartDivision of Cardiovascular Diseases[J]. Rev Esp Cardiol, 2011,64(2):140-149.
4Lau CP, Tse HF, Siu CW, et al. Atrial electrical and structural remod-eling: implications for racial differences in atrial fibrillation[J]. J Car-diovasc Electrophysiol, 2012,23 Suppl l:s36-40.
5Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy C-reac-tiveDrotein attenuates nitric oxide production and inhibits angiogene-sis[J].Circulation,2002,106(8):913-919.
6Shiroshita TA, Schram G, Lavoie J, et al. Effect of simvastafinan d an-tioxidant vitamins on atrial fibrillation promotion by atrial-taehycar-dia remodeling in dogs[J]. Criculation, 2004,110(16):2313-2319.
7Young-Xu Y, Jabbour S, Goldberg R, et al. Usefulness of statin drugsin protecting against atrial fibrillation in patients with coronary arterydisease. [J]. Am J Cardiol,2003,92(12):1379-1383.
8Choi BJ, Heo JH, Choi IS, et al. Hypoadiponectinemia in patientswith paroxysmal atrial fibrillation [J]. Korean Circ J, 2012,42(10):668-673.
9Soeki T, Sata M. Role of epicardial adipose tissue in atrial fibrilla-tion[J]. Circ J, 2012,22,76(12):2738-2739.
10Nakanishi K, Fukuda S, Tanaka A, et al. Peri-atrial epicardial adiposetissue is associated with new-onset nonvalvular atrial fibrillation [J].Circ J, 2012,22,76(12):2748-2754.
